News

In terms of profitability metrics, the company forecasts earnings per share (EPS) to range between $0.70 and $1.10. Excluding the impact of certain one-off items, adjusted EPS is expected to increase to between $0.80 and $1.20. This performance guidance reflects the company's optimistic outlook for medium- and long-term growth prospects. The revenue guidance range takes into account the effects of implementing global market expansion strategies, while the disclosure of dual EPS metrics provides investors with a more comprehensive assessment of earnings quality.

According to the latest forecasts, the company expects its full-year comparable sales growth rate to remain in the range of 1.5% to 2.5%, demonstrating its steady development trend in the organic food retail sector. In terms of profitability indicators, the company's adjusted earnings per share are expected to be in the range of $2.07 to $2.15, reflecting management's confidence in the continuous optimization of profitability. Meanwhile, capital expenditure is set between $45 million and $50 million, with these funds primarily allocated to store network expansion and digital infrastructure upgrades. This updated outlook highlights the company's strategic deployment to maintain business growth resilience amid the current macroeconomic environment, while also providing investors with an important reference point for assessing future performance.

The company expects total annual revenue to reach the range of $3.8 billion to $4.1 billion, demonstrating robust growth momentum. In terms of profitability, Astrana Health expects adjusted EBITDA to be between $250 million and $280 million, fully reflecting the ongoing optimization of the company’s operational efficiency. More notably, the company’s forecast for free cash flow remains at the level of $105 million to $1.325 billion. Strong cash flow generation will provide solid support for Astrana Health’s future development strategies. The reaffirmed earnings guidance is entirely consistent with the company’s previously announced expectations, highlighting management’s full confidence in achieving these financial goals.